Noul
노을 · 376930
Health Care Medical Devices · KOSDAQ
Market cap US$35.9M (₩49.5B)
Overview
Noul makes miLab™, a compact, toaster-sized device that automates blood and cancer diagnostic tests, including malaria screening, peripheral blood analysis, and cervical cell analysis, without requiring specialist laboratory staff.
It supplies this system to diagnostic laboratories worldwide, with a particular focus on small and mid-sized labs that lack the infrastructure or trained personnel for conventional microscopy-based testing. Listed on KOSDAQ, Korea's tech-focused small-cap board, Noul's platform runs its AI analysis entirely on the device itself, requiring no internet connection or cloud server.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$2M
- FY2024US$1.2M
- FY2025US$3.7M
Operating profit
- FY2023−US$11.7M
- FY2024−US$16.5M
- FY2025−US$14.6M
Net income
- FY2023−US$11.8M
- FY2024−US$16.3M
- FY2025−US$14.5M
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?